BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 22, Issue 44
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9757)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.
Item 
Count 
PDF720
WORD286
HTML4845
Figures (1-4)225
Tables (1-3)233
 Sum=6309
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1199
Download2249
 Sum=3448
Nov 28, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Liu XL, Pan Q, Zhang RN, Shen F, Yan SY, Sun C, Xu ZJ, Chen YW, Fan JG. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World J Gastroenterol 2016; 22(44): 9844-9852 [PMID: 27956809 DOI: 10.3748/wjg.v22.i44.9844]
URL: https://www.wjgnet.com/1007-9327/full/v22/i44/9844.htm
Number Citing Articles
1
Siti Aishah Sulaiman, Nor I. A. Muhsin, Rahman Jamal. Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00279
2
Teodora Isac, Sebastian Isac, Razvan Rababoc, Mihail Cotorogea, Laura Iliescu. Epigenetics in inflammatory liver diseases: A clinical perspective (Review). Experimental and Therapeutic Medicine 2022; 23(5) doi: 10.3892/etm.2022.11293
3
Igor P Pogribny. MicroRNAs as biomarkers for clinical studies. Experimental Biology and Medicine 2018; 243(3): 283 doi: 10.1177/1535370217731291
4
Long-Yuan Zhou, Si-Nan Lin, Florian Rieder, Min-Hu Chen, Sheng-Hong Zhang, Ren Mao. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to Bedside. Inflammatory Bowel Diseases 2021; 27(7): 971 doi: 10.1093/ibd/izaa321
5
Xiaofang Zhang, Eralda Asllanaj, Masoud Amiri, Eliana Portilla‐Fernandez, Wichor M. Bramer, Jana Nano, Trudy Voortman, Qiuwei Pan, Mohsen Ghanbari. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review. European Journal of Clinical Investigation 2021; 51(5) doi: 10.1111/eci.13479
6
Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland. Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(1): 195 doi: 10.3390/biomedicines10010195
7
Micaela Gliozzi, Vincenzo Musolino, Francesca Bosco, Miriam Scicchitano, Federica Scarano, Saverio Nucera, Maria Caterina Zito, Stefano Ruga, Cristina Carresi, Roberta Macrì, Lorenza Guarnieri, Jessica Maiuolo, Annamaria Tavernese, Anna Rita Coppoletta, Caterina Nicita, Rocco Mollace, Ernesto Palma, Carolina Muscoli, Catherine Belzung, Vincenzo Mollace. Cholesterol homeostasis: Researching a dialogue between the brain and peripheral tissues. Pharmacological Research 2021; 163: 105215 doi: 10.1016/j.phrs.2020.105215
8
Jose Tadeu Stefano, Fernanda de Mello Malta, Priscila Brizola de Campos, Pedro Fernandes Andrade, Denise Cerqueira Paranaguá-Vezzozo, Flair Jose Carrilho, Claudia P. Oliveira. NAFLD and NASH. 2020; : 191 doi: 10.1007/978-3-030-37173-9_11
9
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24): 3959 doi: 10.3390/cells11243959
10
Shengliang Xin, Qiao Zhan, Xiaofan Chen, Jinghang Xu, Yanyan Yu. Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01334-8
11
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, Jin Wang. Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(3): 2844 doi: 10.3390/ijms24032844
12
Xiao-Lin Liu, Hai-Xia Cao, Bao-Can Wang, Feng-Zhi Xin, Rui-Nan Zhang, Da Zhou, Rui-Xu Yang, Ze-Hua Zhao, Qin Pan, Jian-Gao Fan. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1. World Journal of Gastroenterology 2017; 23(46): 8140-8151 doi: 10.3748/wjg.v23.i46.8140
13
Andrey Turchinovich, Ancha Baranova, Oksana Drapkina, Alexander Tonevitsky. Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01256
14
Yu Sun, Yongming Shen, Xiurui Liang, Huilin Zheng, Yitong Zhang. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review. Clinical Therapeutics 2023; 45(3): 234 doi: 10.1016/j.clinthera.2023.02.001
15
Naga Swetha Samji, Peter D. Snell, Ashwani K. Singal, Sanjaya K. Satapathy. Racial Disparities in Diagnosis and Prognosis of Nonalcoholic Fatty Liver Disease. Clinical Liver Disease 2020; 16(2): 66 doi: 10.1002/cld.948
16
Hung-Yu Lin, Ya-Ling Yang, Pei-Wen Wang, Feng-Sheng Wang, Ying-Hsien Huang. The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond. Cells 2020; 9(4): 1041 doi: 10.3390/cells9041041
17
Monika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti. miRNAs and NAFLD: from pathophysiology to therapy. Gut 2019; 68(11): 2065 doi: 10.1136/gutjnl-2018-318146
18
Yong-Hong Zhang, Heng-Li Xie, Yu-Wei Yang, Jie Wen, Ran-Ran Liu, Gui-Ping Zhao, Xiao-Dong Tan, Zhen Liu, Yi Zheng, Jia-Bao Zhang. miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ). Poultry Science 2023; 102(1): 102218 doi: 10.1016/j.psj.2022.102218
19
Manvita Mareboina, Elen Deng, Ioannis Mouratidis, Nelson S. Yee, Nelly Pitteloud, Ilias Georgakopoulos-Soares, Dionysios V. Chartoumpekis. A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes. Molecular Metabolism 2024; 87: 101987 doi: 10.1016/j.molmet.2024.101987
20
Chenggui Miao, Zhongwen Xie, Jun Chang. Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential Directions. Biochemical Genetics 2018; 56(5): 423 doi: 10.1007/s10528-018-9870-9
21
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(11): 1115 doi: 10.3390/metabo13111115
22
Maria Vulf, Daria Shunkina, Aleksandra Komar, Maria Bograya, Pavel Zatolokin, Elena Kirienkova, Natalia Gazatova, Ivan Kozlov, Larisa Litvinova. Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.736677
23
Mireia López-Riera, Isabel Conde, Guillermo Quintas, Laia Pedrola, Ángela Zaragoza, Judith Perez-Rojas, Mario Salcedo, Salvador Benlloch, José V. Castell, Ramiro Jover. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28854-4
24
Amila Iriskic Atic, Maja Thiele, Alexander Munk, Louise Torp Dalgaard. Circulating miRNAs associated with nonalcoholic fatty liver disease. American Journal of Physiology-Cell Physiology 2023; 324(2): C588 doi: 10.1152/ajpcell.00253.2022
25
Changzhou Cai, Yiming Lin, Chaohui Yu. Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/2096161
26
Andrea R. López-Pastor, Jorge Infante-Menéndez, Óscar Escribano, Almudena Gómez-Hernández. miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.527059
27
Valerio Rosato, Mario Masarone, Andrea Aglitti, Marcello Persico. The diagnostic conundrum in non-alcoholic fatty liver disease. Exploration of Medicine 2020; 1(5) doi: 10.37349/emed.2020.00018
28
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. El grosor y una expresión de miARN alterada en la grasa epicárdica se asocian con enfermedad coronaria en víctimas de muerte súbita. Revista Española de Cardiología 2019; 72(1): 30 doi: 10.1016/j.recesp.2017.12.003
29
Sneha S. Pillai, Hari Vishal Lakhani, Mishghan Zehra, Jiayan Wang, Anum Dilip, Nitin Puri, Kathleen O’Hanlon, Komal Sodhi. Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population. International Journal of Molecular Sciences 2020; 21(18): 6698 doi: 10.3390/ijms21186698
30
Valentina Cossiga, Vincenzo Lembo, Cecilia Nigro, Paola Mirra, Claudia Miele, Valeria D’Argenio, Alessia Leone, Giovanna Mazzone, Iolanda Veneruso, Maria Guido, Francesco Beguinot, Nicola Caporaso, Filomena Morisco. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. Nutrients 2021; 13(4): 1281 doi: 10.3390/nu13041281
31
Johanna K. DiStefano, Xiumei Wu. Epigenetics in Organ Specific Disorders. 2023; : 423 doi: 10.1016/B978-0-12-823931-5.00006-2
32
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
33
Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, Rocío Montero-Vallejo, Ángela Rojas, Rocío Muñoz-Hernández, Rocío Gallego-Durán, Manuel Romero-Gómez. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 2018; 69(6): 1335 doi: 10.1016/j.jhep.2018.08.008
34
Marcello Dallio, Mario Romeo, Antonietta Gerarda Gravina, Mario Masarone, Tiziana Larussa, Ludovico Abenavoli, Marcello Persico, Carmelina Loguercio, Alessandro Federico. Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives. Nutrients 2021; 13(5): 1679 doi: 10.3390/nu13051679
35
Xue Fan, Ya Xing, Long Liu, Chao Zhao, Zhenzhen Chen, Mawahib K. Khogali, Minmeng Zhao, Xuming Hu, Hengmi Cui, Tuoyu Geng, Daoqing Gong. Screening of MicroRNAs with Potential Systemic Effects Released from Goose Fatty Liver. The Journal of Poultry Science 2021; 58(4): 263 doi: 10.2141/jpsa.0200097
36
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2020; 14(8): 733 doi: 10.1080/17474124.2020.1780915
37
Zhijing Wang, Yaru Zhu, Lu Xia, Jing Li, Meiyi Song, Changqing Yang. Exercise-Induced ADAR2 Protects against Nonalcoholic Fatty Liver Disease through miR-34a. Nutrients 2022; 15(1): 121 doi: 10.3390/nu15010121
38
Yi-Jie Li, Brittney O Baumert, Nikos Stratakis, Jesse A Goodrich, Hao-Tian Wu, Jing-Xuan He, Yin-Qi Zhao, Max T Aung, Hong-Xu Wang, Sandrah P Eckel, Douglas I Walker, Damaskini Valvi, Michele A La Merrill, Justin R Ryder, Thomas H Inge, Todd Jenkins, Stephanie Sisley, Rohit Kohli, Stavra A Xanthakos, Andrea A Baccarelli, Rob McConnell, David V Conti, Lida Chatzi. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
39
Mohammed Eslam, Luca Valenti, Stefano Romeo. Genetics and epigenetics of NAFLD and NASH: Clinical impact. Journal of Hepatology 2018; 68(2): 268 doi: 10.1016/j.jhep.2017.09.003
40
A. Baranova, D. Maltseva, A. Tonevitsky. Adipose may actively delay progression of NAFLD by releasing tumor‐suppressing, anti‐fibrotic miR‐122 into circulation. Obesity Reviews 2019; 20(1): 108 doi: 10.1111/obr.12765
41
Shalini R. Dubey, Tester F. Ashavaid, Philip Abraham, Minal Umesh Paradkar. Factors influencing circulating microRNAs as biomarkers for liver diseases. Molecular Biology Reports 2022; 49(6): 4999 doi: 10.1007/s11033-022-07170-1
42
José Del Campo, Rocío Gallego-Durán, Paloma Gallego, Lourdes Grande. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). International Journal of Molecular Sciences 2018; 19(3): 911 doi: 10.3390/ijms19030911
43
Halla M. Ragab, Wafaa M. Ezzat, Eman Mahmoud Hassan, Nabila Abd El Maksoud, Mie Afify, Mohamed D.E. Abd El-Maksoud, Wafaa Abd Elaziz. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease. Journal of Genetic Engineering and Biotechnology 2023; 21(1): 13 doi: 10.1186/s43141-023-00467-z
44
Xing-Ya Guo, Fang Sun, Jian-Neng Chen, Yu-Qin Wang, Qin Pan, Jian-Gao Fan. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World Journal of Gastroenterology 2018; 24(3): 323-337 doi: 10.3748/wjg.v24.i3.323
45
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. Microorganisms 2020; 8(10): 1526 doi: 10.3390/microorganisms8101526
46
Mona N. BinMowyna, Nora A. AlFaris, Ekram A. Al-Sanea, Jozaa Z. AlTamimi, Tahany S. Aldayel. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis. Archives of Physiology and Biochemistry 2024; 130(3): 300 doi: 10.1080/13813455.2022.2046106
47
Lin Ru, Xiao-mei Wang, Jun-qi Niu. The miR-23–27–24 cluster: an emerging target in NAFLD pathogenesis. Acta Pharmacologica Sinica 2022; 43(5): 1167 doi: 10.1038/s41401-021-00819-w
48
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
49
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. International Journal of Molecular Sciences 2021; 22(21): 11905 doi: 10.3390/ijms222111905
50
Zixuan Zhang, Rachel Moon, James L. Thorne, J. Bernadette Moore. NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways. Nutrition Research Reviews 2023; 36(1): 120 doi: 10.1017/S095442242100038X
51
Polina Soluyanova, Guillermo Quintás, Álvaro Pérez-Rubio, Iván Rienda, Erika Moro, Marcel van Herwijnen, Marcha Verheijen, Florian Caiment, Judith Pérez-Rojas, Ramón Trullenque-Juan, Eugenia Pareja, Ramiro Jover. The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis. Biomolecules 2024; 14(11): 1423 doi: 10.3390/biom14111423
52
Jenny Lee, Yasaman Vali, Jérôme Boursier, Kevin Duffin, Joanne Verheij, M. Julia Brosnan, Koos Zwinderman, Quentin M. Anstee, Patrick M. Bossuyt, Mohammad Hadi Zafarmand, Pavel Strnad. Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis. PLOS ONE 2020; 15(9): e0238717 doi: 10.1371/journal.pone.0238717
53
Matthew J Watt, Paula M Miotto, William De Nardo, Magdalene K Montgomery. The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance. Endocrine Reviews 2019; 40(5): 1367 doi: 10.1210/er.2019-00034
54
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. International Journal of Molecular Sciences 2021; 22(14): 7716 doi: 10.3390/ijms22147716
55
Xiao‐Lin Liu, Qin Pan, Hai‐Xia Cao, Feng‐Zhi Xin, Ze‐Hua Zhao, Rui‐Xu Yang, Jing Zeng, Huiping Zhou, Jian‐Gao Fan. Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. Hepatology 2020; 72(2): 454 doi: 10.1002/hep.31050
56
Sanjukta Mishra, RajLaxmi Sarangi, Swarnalata Das, Amresh Mishra. Nonalcoholic Fatty Liver Disease and MicroRNAs. Biomedical and Biotechnology Research Journal (BBRJ) 2023; 7(1): 1 doi: 10.4103/bbrj.bbrj_319_22
57
Sheng Yang, Chong Liu, Xiaowen Ji, Xuemin Chen, Yun Wang, Rong Tao. The Role of Gold Nanorods in Detecting Circulating microRNAs as Biomarkers in Liver Diseases. Journal of Biomedical Nanotechnology 2023; 19(10): 1721 doi: 10.1166/jbn.2023.3676
58
Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll, Henning Grønbæk. Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD. Current Hepatology Reports 2017; 16(4): 308 doi: 10.1007/s11901-017-0369-3
59
Chuwei Yu, Jing Chen, Jin Ren. Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment. Molecular Biology Reports 2022; 49(10): 9841 doi: 10.1007/s11033-022-07503-0
60
Josep Marí-Alexandre, Moises Barceló-Molina, Jorge Sanz-Sánchez, Pilar Molina, Jennifer Sancho, Yolanda Abellán, María Luisa Santaolaria-Ayora, Juan Giner, Luis Martínez-Dolz, Amparo Estelles, Aitana Braza-Boïls, Esther Zorio. Thickness and an Altered miRNA Expression in the Epicardial Adipose Tissue Is Associated With Coronary Heart Disease in Sudden Death Victims. Revista Española de Cardiología (English Edition) 2019; 72(1): 30 doi: 10.1016/j.rec.2017.12.007
61
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021;  doi: 10.7759/cureus.20776
62
Xiaoyan Qi, Jinping Lai. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences 2022; 23(21): 13501 doi: 10.3390/ijms232113501
63
Xuemei Tao, Lin Chen, Youfei Zhao, Yonggang Liu, Ruifang Shi, Bei Jiang, Yuqiang Mi, Liang Xu. A Novel Noninvasive Diagnostic Model of HBV-Related Inflammation in Chronic Hepatitis B Virus Infection Patients With Concurrent Nonalcoholic Fatty Liver Disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.862879
64
Minakshi Rana, Manisha Saini, Rina Das, Sumeet Gupta, Tanishq Joshi, Dinesh Kumar Mehta. Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detection of Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma. MicroRNA 2023; 12(2): 99 doi: 10.2174/2211536612666230330083146
65
Nimish Thakral, Hailemichael Desalegn, Luis Antonio Diaz, Daniel Cabrera, Rohit Loomba, Marco Arrese, Juan Pablo Arab. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD. Seminars in Liver Disease 2024; 44(03): 273 doi: 10.1055/a-2364-2928
66
Rok Razpotnik, Petra Nassib, Tanja Kunej, Damjana Rozman, Tadeja Režen. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(14): 7477 doi: 10.3390/ijms22147477
67
S. Georgiou, V. Pantazopoulou, Ema Anastasiadou. The Human Gut-Liver-Axis in Health and Disease. 2019; : 207 doi: 10.1007/978-3-319-98890-0_13
68
Amal A. Mohamed, Ahmed El-Demery, Eman Al-Hussain, Shroouk Mousa, Ahmed Abdel Halim, Sahar M. Mostafa, Reda S. Abdelghany, Seham M. Mahmoud, Mohammad A. Elkady, Khaled Raafat, Alshymaa A. Hassnine, Mohamed M. Omran. NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients. Journal of Genetic Engineering and Biotechnology 2021; 19(1): 157 doi: 10.1186/s43141-021-00257-5
69
Sanchari Roy, Christian Trautwein, Tom Luedde, Christoph Roderburg. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00805
70
Yu‐e Qin, Li Duan, Yumin He, Chengfu Yuan, Ting Wang, Ding Yuan, Changcheng Zhang, Chaoqi Liu. Saturated Fatty Acids Promote Hepatocytic Senecence through Regulation of miR‐34a/Cyclin‐Dependent Kinase 6. Molecular Nutrition & Food Research 2020; 64(23) doi: 10.1002/mnfr.202000383
71
Akshatha N. Srinivas, Diwakar Suresh, Savneet Kaur, Divya P. Kumar. The promise of small particles: extracellular vesicles as biomarkers in liver pathology. The Journal of Physiology 2023; 601(22): 4953 doi: 10.1113/JP283074
72
Lygia N. Barroso, Jessica Salarini, Nathalie Carvalho Leite, Cristiane A. Villela-Nogueira, Alberto Dávalos, Maria das Graças Tavares Carmo, Wilza Arantes Ferreira Peres. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial. Clinical Nutrition ESPEN 2023; 57: 117 doi: 10.1016/j.clnesp.2023.06.027
73
Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri, Sneha S. Pillai. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. Biomedicines 2023; 11(6): 1597 doi: 10.3390/biomedicines11061597
74
Jorge-Luis Torres, Ignacio Novo-Veleiro, Laura Manzanedo, Lucía Alvela-Suárez, Ronald Macías, Francisco-Javier Laso, Miguel Marcos. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2018; 24(36): 4104-4118 doi: 10.3748/wjg.v24.i36.4104
75
Dada Wen, Huamin Zhang, Yutong Zhou, Jie Wang. The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. International Journal of Molecular Sciences 2022; 23(24): 16041 doi: 10.3390/ijms232416041
76
Lucy Petagine, Mohammed Gulrez Zariwala, Vinood B Patel. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World Journal of Gastroenterology 2023; 29(32): 4831-4850 doi: 10.3748/wjg.v29.i32.4831
77
Fatemeh Amani, Amirhossein Sahebkar, Seyed Hamid Aghaee-Bakhtiari, Mohammadreza Farzanehfar, Saeedeh Askarian, Reza Kazemi Oskuee. Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease. Gene Reports 2024; 36: 101964 doi: 10.1016/j.genrep.2024.101964
78
Jian-Rong Li, Chun-Yip Tong, Tsai-Jung Sung, Ting-Yu Kang, Xianghong Jasmine Zhou, Chun-Chi Liu, Janet Kelso. CMEP: a database for circulating microRNA expression profiling. Bioinformatics 2019; 35(17): 3127 doi: 10.1093/bioinformatics/btz042
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345